Differential Gene Expression in the EphA4 Knockout Spinal Cord and Analysis of the Inflammatory Response Following Spinal Cord Injury

Mice lacking the axon guidance molecule EphA4 have been shown to exhibit extensive axonal regeneration and functional recovery following spinal cord injury. To assess mechanisms by which EphA4 may modify the response to neural injury a microarray was performed on spinal cord tissue from mice with spinal cord injury and sham injured controls. RNA was purified from spinal cords of adult EphA4 knockout and wild-type mice four days following lumbar spinal cord hemisection or laminectomy only and was hybridised to Affymetrix All-Exon Array 1.0 GeneChips™. While subsequent analyses indicated that several pathways were altered in EphA4 knockout mice, of particular interest was the attenuated expression of a number of inflammatory genes, including Arginase 1, expression of which was lower in injured EphA4 knockout compared to wild-type mice. Immunohistological analyses of different cellular components of the immune response were then performed in injured EphA4 knockout and wildtype spinal cords. While numbers of infiltrating CD3+ T cells were low in the hemisection model, a robust CD11b+ macrophage/microglial response was observed post-injury. There was no difference in the overall number or spread of macrophages/activated microglia in injured EphA4 knockout compared to wild-type spinal cords at 2, 4 or 14 days post-injury, however a lower proportion of Arginase-1 immunoreactive macrophages/activated microglia was observed in EphA4 knockout spinal cords at 4 days post-injury. Subtle alterations in the neuroinflammatory response in injured EphA4 knockout spinal cords may contribute to the regeneration and recovery observed in these mice following injury

Spatio-Temporal Progression of Grey and White Matter Damage Following Contusion Injury in Rat Spinal Cord

Cellular mechanisms of secondary damage progression following spinal cord injury remain unclear. We have studied the extent of tissue damage from 15 min to 10 weeks after injury using morphological and biochemical estimates of lesion volume and surviving grey and white matter. This has been achieved by semi-quantitative immunocytochemical methods for a range of cellular markers, quantitative counts of white matter axonal profiles in semi-thin sections and semi-quantitative Western blot analysis, together with behavioural tests (BBB scores, ledged beam, random rung horizontal ladder and DigiGait™ analysis). We have developed a new computer-controlled electronic impactor based on a linear motor that allows specification of the precise nature, extent and timing of the impact. Initial (15 min) lesion volumes showed very low variance (1.92±0.23 mm3, mean±SD, n = 5). Although substantial tissue clearance continued for weeks after injury, loss of grey matter was rapid and complete by 24 hours, whereas loss of white matter extended up to one week. No change was found between one and 10 weeks after injury for almost all morphological and biochemical estimates of lesion size or behavioural methods. These results suggest that previously reported apparent ongoing injury progression is likely to be due, to a large extent, to clearance of tissue damaged by the primary impact rather than continuing cell death. The low variance of the impactor and the comprehensive assessment methods described in this paper provide an improved basis on which the effects of potential treatment regimes for spinal cord injury can be assessed

Toxin-Based Models to Investigate Demyelination and Remyelination.

Clinical myelin diseases, and our best experimental approximations, are complex entities in which demyelination and remyelination proceed unpredictably and concurrently. These features can make it difficult to identify mechanistic details. Toxin-based models offer lesions with predictable spatiotemporal patterns and relatively discrete phases of damage and repair: a simpler system to study the relevant biology and how this can be manipulated. Here, we discuss the most widely used toxin-based models, with a focus on lysolecithin, ethidium bromide, and cuprizone. This includes an overview of their respective mechanisms, strengths, and limitations and step-by-step protocols for their use

Inflammation-induced Decrease In Voluntary Wheel Running In Mice: A Nonreflexive Test For Evaluating Inflammatory Pain And Analgesia

Inflammatory pain impacts adversely on the quality of life of patients, often resulting in motor disabilities. Therefore, we studied the effect of peripheral inflammation induced by intraplantar administration of complete Freund's adjuvant (CFA) in mice on a particular form of voluntary locomotion, wheel running, as an index of mobility impairment produced by pain. The distance traveled over 1 hour of free access to activity wheels decreased significantly in response to hind paw inflammation, peaking 24 hours after CFA administration. Recovery of voluntary wheel running by day 3 correlated with the ability to support weight on the inflamed limb. Inflammation-induced mechanical hypersensitivity, measured with von Frey hairs, lasted considerably longer than the impaired voluntary wheel running and is not driving; therefore, the change in voluntary behavior. The CFA-induced decrease in voluntary wheel running was dose-dependently reversed by subcutaneous administration of antiinflammatory and analgesic drugs, including naproxen (10-80 mg/kg), ibuprofen (2.5-20 mg/kg), diclofenac (1.25-10 mg/kg), celecoxib (2.5-20 mg/kg), prednisolone (0.62-5 mg/kg), and morphine (0.06-0.5 mg/kg), all at much lower doses than reported in most rodent models. Furthermore, the doses that induced recovery in voluntary wheel running did not reduce CFA-induced mechanical allodynia, indicating a greater sensitivity of the former as a surrogate measure of inflammatory pain. We conclude that monitoring changes in voluntary wheel running in mice during peripheral inflammation is a simple, observer-independent objective measure of functional changes produced by inflammation, likely more aligned to the global level of pain than reflexive measures, and much more sensitive to analgesic drug effects. © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.1534876884Andrews, N., Legg, E., Lisak, D., Issop, Y., Richardson, D., Harper, S., Huang, W., Rice, A.S., Spontaneous burrowing behaviour in the rat is reduced by peripheral nerve injury or inflammation associated pain (2011) Eur J Pain, , [Epub ahead of print]Blackburn-Munro, G., Pain-like behaviours in animals - How human are they? (2004) Trends in Pharmacological Sciences, 25 (6), pp. 299-305. , DOI 10.1016/j.tips.2004.04.008, PII S0165614704001208Boyce-Rustay, J.M., Zhong, C., Kohnken, R., Baker, S.J., Simler, G.H., Wensink, E.J., Decker, M.W., Honore, P., Comparison of mechanical allodynia and the affective component of inflammatory pain in rats (2010) Neuropharmacology, 58, pp. 537-543Chesler, E.J., Wilson, S.G., Lariviere, W.R., Rodriguez-Zas, S.L., Mogil, J.S., Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive (2002) Neuroscience and Biobehavioral Reviews, 26 (8), pp. 907-923. , DOI 10.1016/S0149-7634(02)00103-3, PII S0149763402001033Chesler, E.J., Wilson, S.G., Rodriguez-Zas, S.L., Mogil, J.S., Influences of laboratory environment on behavior (2002) Nat Neurosci, 5, pp. 1101-1102Colpaert, F.C., Tarayre, J.P., Alliaga, M., Bruins Slot, L.A., Attal, N., Koek, W., Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats (2001) Pain, 91 (1-2), pp. 33-45. , DOI 10.1016/S0304-3959(00)00413-9, PII S0304395900004139Doyle, G., Jayawardena, S., Ashraf, E., Cooper, S.A., Efficacy and tolerability of nonprescription Ibuprofen versus Celecoxib for dental pain (2002) Journal of Clinical Pharmacology, 42 (8), pp. 912-919. , DOI 10.1177/009127002401102830El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., Vaugeois, J.-M., The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists (2000) Psychopharmacology, 148 (2), pp. 153-163Elhabazi, K., Trigo, J., Mollereau, C., Moulédous, L., Zajac, J.M., Bihel, F., Schmitt, M., Simonin, F., Involvement of neuropeptide FF receptors in neuroadaptative responses to acute and chronic opiate treatments (2012) Br J Pharmacol, 165, pp. 424-443Gabriel, A.F., Marcus, M.A.E., Honig, W.M.M., Walenkamp, G.H.I.M., Joosten, E.A.J., The CatWalk method: A detailed analysis of behavioral changes after acute inflammatory pain in the rat (2007) Journal of Neuroscience Methods, 163 (1), pp. 9-16. , DOI 10.1016/j.jneumeth.2007.02.003, PII S0165027007000660Gøtzsche, P.C., Johansen, H.K., Short-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis (2009) Cochrane Database Syst Rev, 1, p. 000189Gutierrez, T., Crystal, J.D., Zvonok, A.M., Makriyannis, A., Hohmann, A.G., Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain (2011) Pain, 152, pp. 1976-1987Hinman, R.S., Bennell, K.L., Crossley, K.M., McConnell, J., Immediate effects of adhesive tape on pain and disability in individuals with knee osteoarthritis (2003) Rheumatology, 42 (7), pp. 865-869. , DOI 10.1093/rheumatology/keg233Hunskaar, S., Hole, K., The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain (1987) Pain, 30 (1), pp. 103-114. , DOI 10.1016/0304-3959(87)90088-1Huntjens, D.R., Spalding, D.J., Danhof, M., Della Pasqua, O.E., Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors (2009) Eur J Pain, 13, pp. 448-457Insel, P.A., Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout (1996) The Pharmacological Basis of Therapeutics, pp. 617-657. , J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, Gilman A. Goodman, McGraw-Hill New YorkJanssens, H.J., Janssen, M., Van De Lisdonk, E.H., Van Riel, P.L., Van Weel, C., Use of oral prednisolone or naproxen for the treatment of gout arthritis: A double-blind, randomised equivalence trial (2008) The Lancet, 371 (9627), pp. 1854-1860. , DOI 10.1016/S0140-6736(08)60799-0, PII S0140673608607990Jones, C.K., Peters, S.C., Shannon, H.E., Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents (2005) Journal of Pharmacology and Experimental Therapeutics, 312 (2), pp. 726-732. , DOI 10.1124/jpet.104.075960Kuphal, K.E., Fibuch, E.E., Taylor, B.K., Extended swimming exercise reduces inflammatory and peripheral neuropathic pain in rodents (2007) Journal of Pain, 8 (12), pp. 989-997. , DOI 10.1016/j.jpain.2007.08.001, PII S1526590007008140Labuda, C.J., Fuchs, P.N., Low dose aspirin attenuates escape/avoidance behavior, but does not reduce mechanical hyperalgesia in a rodent model of inflammatory pain (2001) Neuroscience Letters, 304 (3), pp. 137-140. , DOI 10.1016/S0304-3940(01)01787-6, PII S0304394001017876Malmstrom, K., Daniels, S., Kotey, P., Seidenberg, B.C., Desjardins, P.J., Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator- controlled clinical trial (1999) Clinical Therapeutics, 21 (10), pp. 1653-1663. , DOI 10.1016/S0149-2918(99)80045-9Martin, T.J., Zhang, Y., Buechler, N., Conklin, D.R., Eisenach, J.C., Intrathecal morphine and ketorolac analgesia after surgery: Comparison of spontaneous and elicited responses in rats (2005) Pain, 113 (3), pp. 376-385. , DOI 10.1016/j.pain.2004.11.017, PII S0304395904005548Matson, D.J., Broom, D.C., Carson, S.R., Baldassari, J., Kehne, J., Cortright, D.N., Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in rats (2007) Journal of Pharmacology and Experimental Therapeutics, 320 (1), pp. 194-201. , http://jpet.aspetjournals.org/cgi/reprint/320/1/194, DOI 10.1124/jpet.106.109736Mogil, J.S., Animal models of pain: Progress and challenges (2009) Nat Rev Neurosci, 10, pp. 283-294Mogil, J.S., Davis, K.D., Derbyshire, S.W., The necessity of animal models in pain research (2010) Pain, 151, pp. 12-17Mogil, J.S., Graham, A.C., Ritchie, J., Hughes, S.F., Austin, J.S., Schorscher-Petcu, A., Langford, D.J., Bennett, G.J., Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice (2010) Mol Pain, 6, p. 34Nagakura, Y., Okada, M., Kohara, A., Kiso, T., Toya, T., Iwai, A., Wanibuchi, F., Yamaguchi, T., Allodynia and hyperalgesia in adjuvant-induced arthritic rats: Time course of progression and efficacy of analgesics (2003) Journal of Pharmacology and Experimental Therapeutics, 306 (2), pp. 490-497. , DOI 10.1124/jpet.103.050781Nieto, F.R., Entrena, J.M., Cendan, C.M., Pozo, E.D., Vela, J.M., Baeyens, J.M., Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice (2008) Pain, 137 (3), pp. 520-531. , DOI 10.1016/j.pain.2007.10.012, PII S0304395907005799Ortiz, M.I., Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides (2011) Pharmacol Biochem Behav, 99, pp. 1-6Patel, S., Naeem, S., Kesingland, A., Froestl, W., Capogna, M., Urban, L., Fox, A., The effects of GABA B agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat (2001) Pain, 90 (3), pp. 217-226. , DOI 10.1016/S0304-3959(00)00404-8, PII S0304395900004048Rice, A.S., Cimino-Brown, D., Eisenach, J.C., Kontinen, V.K., Lacroix-Fralish, M.L., MacHin, I., Mogil, J.S., Stöhr, T., Animal models and the prediction of efficacy in clinical trials of analgesic drugs: A critical appraisal and call for uniform reporting standards (2008) Pain, 139, pp. 243-247Sahin, N.O., Librowski, T., Investigations of anti-inflammatory and analgesic activities of prednisolone solid dispersion prepared with skimmed milk (2003) Polish Journal of Pharmacology, 55 (2), pp. 261-265Sanchez, K., Papelard, A., Nguyen, C., Bendeddouche, I., Jousse, M., Rannou, F., Revel, M., Poiraudeau, S., McMaster-Toronto arthritis patient preference disability questionnaire sensitivity to change in low back pain: Influence of shifts in priorities (2011) PLoS One, 6, p. 20274Sherwin, C.M., Voluntary wheel running: A review and novel interpretation (1998) Animal Behaviour, 56 (1), pp. 11-27. , DOI 10.1006/anbe.1998.0836Smith, G.D., Harrison, S.M., Birch, P.J., Elliott, P.J., Malcangio, M., Bowery, N.G., Increased sensitivity to the antinociceptive activity of (±)-Baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia (1994) Neuropharmacology, 33 (9), pp. 1103-1108. , DOI 10.1016/0028-3908(94)90149-XStevenson, G.W., Cormier, J., Mercer, H., Adams, C., Dunbar, C., Negus, S.S., Bilsky, E.J., Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: Drug effects on acetic acid-depressed locomotor activity in ICR mice (2009) Life Sci, 85, pp. 309-315Stevenson, G.W., Mercer, H., Cormier, J., Dunbar, C., Benoit, L., Adams, C., Jezierski, J., Bilsky, E.J., Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: Implications for preclinical behavioral assessment of chronic pain (2011) Pharmacol Biochem Behav, 98, pp. 35-42Tegeder, I., Niederberger, E., Vetter, G., Brautigam, L., Geisslinger, G., Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E 2 release in the spinal cord (2001) Journal of Neurochemistry, 79 (4), pp. 777-786. , DOI 10.1046/j.1471-4159.2001.00613.xTétreault, P., Dansereau, M.A., Doré-Savard, L., Beaudet, N., Sarret, P., Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats (2011) Physiol Behav, 104, pp. 495-502Urban, R., Scherrer, G., Goulding, E.H., Tecott, L.H., Basbaum, A.I., Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity (2011) Pain, 152, pp. 990-1000Verhoeven, A.C., Boers, M., Van Der Liden, S., Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. The McMaster Toronto Arthritis (2000) J Rheumatol, 27, pp. 2801-2809Vierck, C.J., Acosta-Rua, A.J., Johnson, R.D., Bilateral chronic constriction of the sciatic nerve: A model of long-term cold hyperalgesia (2005) Journal of Pain, 6 (8), pp. 507-517. , DOI 10.1016/j.jpain.2005.03.003, PII S1526590005005341Vierck, C.J., Hansson, P.T., Yezierski, R.P., Clinical and pre-clinical pain assessment: Are we measuring the same thing? (2008) Pain, 135, pp. 7-10Vierck Jr., C.J., Kline IV, R.H., Wiley, R.G., Intrathecal substance P-saporin attenuates operant escape from nociceptive thermal stimuli (2003) Neuroscience, 119 (1), pp. 223-232. , DOI 10.1016/S0306-4522(03)00125-8Villanueva, L., Is there a gap between preclinical and clinical studies of analgesia? (2000) Trends Pharmacol Sci, 21, pp. 461-462. , author reply 465Waldhoer, M., Bartlett, S.E., Whistler, J.L., Opioid receptors (2004) Annual Review of Biochemistry, 73, pp. 953-990. , DOI 10.1146/annurev.biochem.73.011303.073940Whiteside, G.T., Harrison, J., Boulet, J., Mark, L., Pearson, M., Gottshall, S., Walker, K., Pharmacological characterisation of a rat model of incisional pain (2004) British Journal of Pharmacology, 141 (1), pp. 85-91. , DOI 10.1038/sj.bjp.0705568Yashpal, K., Coderre, T.J., Influence of formalin concentration on the antinociceptive effects of anti-inflammatory drugs in the formalin test in rats: Separate mechanisms underlying the nociceptive effects of low- and high-concentration formalin (1998) European Journal of Pain, 2 (1), pp. 63-68. , DOI 10.1016/S1090-3801(98)90047-7Zimmermann, M., Ethical guidelines for investigations of experimental pain in conscious animals (1983) Pain, 16 (2), pp. 109-110. , DOI 10.1016/0304-3959(83)90201-

Phospholipase A2 superfamily members play divergent roles after spinal cord injury

Spinal cord injury (SCI) results in permanent loss of motor functions. A significant aspect of the tissue damage and functional loss may be preventable as it occurs, secondary to the trauma. We show that the phospholipase A 2 (PLA2) superfamily plays important roles in SCI. PLA2 enzymes hydrolyze membrane glycerophospholipids to yield a free fatty acid and lysophospholipid. Some free fatty acids (arachidonic acid) give rise to eicosanoids that promote inflammation, while some lysophospholipids (lysophosphatidylcholine) cause demyelination. We show in a mouse model of SCI that two cytosolic forms [calcium-dependent PLA2 group IVA (cPLA 2 GIVA) and calcium-independent PLA2 group VIA (iPLA 2 GVIA)], and a secreted form [secreted PLA2group IIA (sPLA2 GIIA)] are up-regulated. Using selective inhibitors and null mice, we show that these PLA2s play differing roles. cPLA2 GIVA mediates protection, whereas sPLA2 GIIA and, to a lesser extent, iPLA2 GVIA are detrimental. Furthermore, completely blocking all three PLA2s worsens outcome, while the most beneficial effects are seen by partial inhibition of all three. The partial inhibitor enhances expression of cPLA2 and mediates its beneficial effects via the prostaglandin EP1 receptor. These findings indicate that drugs that inhibit detrimental forms of PLA2 (sPLA2 and iPLA2) and upregulate the protective form (cPLA2) may be useful for the treatment of SCI. © FASEB